期刊文献+

纤溶酶原激活物抑制物-1基因4G/5G位点多态性与脑梗死的相关性研究 被引量:2

The relationship of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and cerebral infarction
下载PDF
导出
摘要 目的研究纤溶酶原激活物抑制物-1(PAI-1)基因4G/5G位点多态性与脑梗死的关系。方法根据急性缺血性脑卒中Org10172治疗试验(TOAST)分型,收集大动脉粥样硬化型(LAA)脑梗死患者125例,小动脉闭塞型(SAO)脑梗死患者147例,以及同期体检中心体检者127例。比较脑梗死患者临床特征及PAI-1基因4G/5G位点多态性。结果与对照组相比,LAA组和SAO组脑梗死患者高血压患病率、吸烟及饮酒比例显著增高,高密度脂蛋白胆固醇(HDL-C)水平低(均<0.05)。LAA组,SAO组及对照组均出现了4G/4G、4G/5G、5G/5G 3种基因型,3组基因型的分布差异有统计学意义(<0.05)。结论高血压、吸烟、饮酒、HDL-C水平降低是温州地区脑梗死患者的重要危险因素。温州地区人群PAI-1基因4G/5G位点4G/5G基因型是脑梗死的危险因素。 Objective To investigate the relationship of plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G pol-ymorphism and cerebral infarction. Methods Data was prospectively collected from consecutive ischemic stroke inpa-tients in neurology department of Wenzhou central hospital. According to the TOAST criteria, 125 large-artery athero-sclerosis (LAA) patients and 147 Small-artery occlusion (SAO) patients were enrolled. The control group had 1 27 sub- jects from the Medical Examination Center in the same period. The clinical characteristics and 4G/5G polymorphism of PAI-1 gene were compared among the three groups. Result As compared with the controls, percentage of high blood pressure (HBP), smoking, drinking, high-density lipoprotein cholesterol concentrations (HDL-C) in LAA and SAO gro-ups (allP 〈 0.05). There were three genotypes (4G/4G、4G/5G、5G/5G) in each groups. There was significantly differ-ence of genotype frequency in the three groups (P 〈 0.05). Conclusion HBP, smoking, drinking, decreasing high-den-sity lipoprotein cholesterol are risk factors of cerebral infarction population in Whenzhou district. The PAI-1 Gene 4G/5G genotype increases the risk of cerebral infarction.
机构地区 温州市中心医院
出处 《现代实用医学》 2016年第8期988-989,1008,共3页 Modern Practical Medicine
基金 浙江省医药卫生科技计划(2011KYA148)
关键词 脑梗塞 纤溶酶原激活物抑制剂-1 基因多态性 Cerebral infarction Plasminogen activator inhibitor-1 Gene polymorphism
  • 相关文献

参考文献7

二级参考文献28

  • 1MinLi Geng-TaoLiu.Inhibition of Fas/FasL mRNA expression and TNF-a release in concanavalin A-induced liver injury in mice by bicyclol[J].World Journal of Gastroenterology,2004,10(12):1775-1779. 被引量:23
  • 2王喜红.百赛诺治疗慢性乙型肝炎早期肝硬化临床观察[J].临床医药实践,2005,14(1):43-44. 被引量:8
  • 3Sarra Saidi,Lamia B. Slamia,Touhami Mahjoub,Sofyan B. Ammou,Wassim Y. Almawi.Association of PAI-1 4G/5G and -844G/A Gene Polymorphism and Changes in PAI-1/tPA Levels in Stroke: A Case-Control Study[J].Journal of Stroke and Cerebrovascular Diseases.2007(4)
  • 4.Plasminogen Activator Inhibitor 4G Polymorphism Is Associated With Decreased Risk of Cerebrovascular Mortality in Older Women[J].Circulation: Journal of the American Heart Association.2000(1)
  • 5Debomoy K. Lahiri,Bill Schnabel.DNA isolation by a rapid method from human blood samples: Effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality[J].Biochemical Genetics (-).1993(7-8)
  • 6March WA,Moore VM,Willson KJ,et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria[J]. Hum Reprod, 2010,25 (2) : 544- 551.
  • 7Li R,Zhang Q,Yang D,et al. Prevalence of polyeystic ovary syndrome in women in China: a large community-based study[J]. Hum Reprod, 2013,28 (9) : 2562-2569.
  • 8Pedroja BS,Kang LE,Imas AO,et al. Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling [J]. J Biol Chem, 2009,284 ( 31 ) : 20708-20717.
  • 9Sales MF,S6ter MO,Candido AL,et al. Correlation between plas- minogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymor- phism and metabolic/proinflammatory factors in polycystic ovary syn- drome[J]. Gynecol Endocrinol, 2013,29 (10) : 936-939.
  • 10Kilicci C, Bayram B, Ozkurt M, et al. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome[J]. Genet Test Mol Biomarkers, 2012,15 ( 7/8 ) : 565-567.

共引文献8

同被引文献4

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部